Page 361 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Giant Cell Arteritis 335

[171] Narvaez J, Bernard B, Gomez-Vaquero C, et al. Impact of antiplatelet therapy in the
development of severe ischaemic complications and in the outcome of patients with
giant cell arteritis. Clin. Exp. Rheumatol., 2008; 26 (Suppl 49):S57-S62.

[172] Berger CT, Wolbers M, Meyer P, et al. High incidence of severe ischaemic
complications in patients with giant cell arteritis irrespective of platelet count and size,
and platelet inhibition. Rheumatology, 2009; 48:258-261.

[173] Mackie S, Dasgupta B, Hordon L et al. Ischaemic manifestations in giant cell arteritis
are associated with area level socio-economic deprivation, but not cardiovascular risk
factors. Rheumatology, 2011; 50:2014-2022.

[174] Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the
diagnosis of temporal arteritis. N. Engl. J. Med., 1997; 337:1336-1342.

Complimentary Contributor Copy